Three months’ clinical outcomes from a nationwide non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis. Results from the DANBIO registry

Bente Glintborg, Inge Juul Sørensen, Dorte Vendelbo Jensen, Niels Steen Krogh, A. G. Loft, A. Colic, J. Espesen, J. Olsen, O. Hendricks, J. Grydehøj, I. M. J. Hansen, M. V. Sørensen, S. Chrysidis, A. Linauskas, H. M. Lindegaard, B. L. Andersen, N. Manilo, Mette Klarlund, L. S. Andersen, H. NordinS. Kristensen, Merete Lund Hetland

Original languageEnglish
Article numberOP07
JournalScandinavian Journal of Rheumatology
Volume45
Issue numberSuppl. 128
Pages (from-to)4-5
Number of pages2
ISSN0300-9742
Publication statusPublished - 2016

Cite this